SleepCogni develops a personalized medical device that utilizes cognitive behavioral therapy techniques to help individuals with insomnia improve their sleep quality. The device has demonstrated significant efficacy in clinical trials, reducing insomnia symptoms within seven days for users.
Funding
$381.3K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Insomnia affects millions, leading to poor sleep quality and significant daytime impairment. Traditional treatments often involve medication or extensive therapy sessions, which can be costly, inaccessible, or come with unwanted side effects. Many individuals struggle to find effective, convenient, and personalized solutions for managing their sleep difficulties.
Solution
SleepCogni offers a personalized, handheld medical device that utilizes cognitive behavioral therapy for insomnia (CBT-I) techniques to improve sleep quality. The device is designed to be simple and easy to use, providing a non-pharmacological approach to calming the mind and promoting relaxation at bedtime. Clinical trials have demonstrated the device's efficacy in reducing insomnia symptoms within seven days. By providing a tangible focus, the device helps users manage overthinking and worry, facilitating a quicker transition to sleep.
Target Audience
The primary target audience includes individuals experiencing insomnia and seeking a convenient, non-pharmacological solution to improve their sleep quality. This includes adults looking for alternatives to medication or traditional therapy.
Features
- Handheld device designed for ease of use and portability
- Integrated cognitive behavioral therapy techniques for insomnia (CBT-I)
- Personalized sleep therapy delivered through the device
- Aims to reduce overthinking and promote relaxation
- Demonstrated efficacy in clinical trials, reducing insomnia symptoms within seven days